NCT00543374 Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT00528073 Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease Status COMPLETED Phase PHASE2
NCT00524537 A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD) Status COMPLETED Phase N/A
NCT00513552 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Status WITHDRAWN Phase PHASE4
NCT00509639 Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease Status COMPLETED Phase PHASE3
NCT00496548 Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity Status COMPLETED Phase NA
NCT00495521 High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children Status TERMINATED Phase PHASE2
NCT00492791 Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy Status COMPLETED Phase N/A
NCT00487396 Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease Status COMPLETED Phase NA
NCT00482092 Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT00467922 An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy Status COMPLETED Phase PHASE3
NCT00446433 A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS) Status COMPLETED Phase PHASE3
NCT00427804 Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption Status COMPLETED Phase NA